Incannex Healthcare (NASDAQ: IXHL) has completed patient dosing…
Continue ReadingTag: Oral
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Patient dosing completed in Phase 2 portion of Phase 2/3 RePOSA study evaluating IHL-42X oral treatment…
Continue Reading